Advances in treating bronchopulmonary dysplasia

Research output: Contribution to journalReview articlepeer-review

11 Citations (Scopus)
486 Downloads (Pure)


Introduction: Bronchopulmonary dysplasia (BPD) is a common long-term adverse complication of very premature delivery. Affected infants can suffer chronic respiratory morbidities including lung function abnormalities and reduced exercise capacity even as young adults. Many studies have investigated possible preventative strategies; however, it is equally important to identify optimum management strategies for infants with evolving or established BPD. Areas covered: Respiratory support modalities and established and novel pharmacological treatments. Expert opinion: Respiratory support modalities including proportional assist ventilation and neurally adjusted ventilatory assist are associated with short term improvements in oxygenation indices. Such modalities need to be investigated in appropriate RCTs. Many pharmacological treatments are routinely used with a limited evidence base, for example diuretics. Stem cell therapies in small case series are associated with promising results. More research is required before it is possible to determine if such therapies should be investigated in large RCTs with long-term outcomes.

Original languageEnglish
Pages (from-to)727-735
Number of pages9
JournalExpert review of respiratory medicine
Issue number8
Early online date2 Jul 2019
Publication statusPublished - 3 Aug 2019


  • Bronchopulmonary dysplasia
  • diuretics
  • mesenchymal stem cells
  • prematurity
  • pulmonary


Dive into the research topics of 'Advances in treating bronchopulmonary dysplasia'. Together they form a unique fingerprint.

Cite this